GSK Archives -

GSK’s ZEJULA gets green light for NHS use

Eloise McLennan GSK, NHS, NICE, ovarian cancer, regulatory approval 0 Comment

The UK’s National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline’s (GSK) ZEJULA (niraparib) for some

GSK’s ZEJULA gets green light for NHS use

https://pharmaphorum.com/news/gsk-zejula-niraparib-gets-green-light-for-nhs-use/

R&D/ Views & Analysis/ Views and analysis

US vs EU: How can Europe translate home-grown innovation into biotech success?

Amanda Barrell BioNTech, Biotech, EU, GSK, Pfizer, Roche, The European Commission 0 Comment

We have seen a boom in biotech initial public offerings over the last two years, but many of

US vs EU: How can Europe translate home-grown innovation into biotech success?

https://pharmaphorum.com/r-d/us-vs-eu-translate-home-grown-innovation-into-biotech-success/

R&D/ Views & Analysis/ Views and analysis

Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4

mike.hammerton@pharmaphorum.com Biogen, GSK, Merck, Q4 2021, quarterly results 0 Comment

While the pandemic has been the focus of R&D attention for much of 2020, that is slowly beginning

Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4

https://pharmaphorum.com/r-d/views-analysis-r-d/pharmas-pipeline-continues-to-provide-drama-as-investors-look-beyond-covid-in-q4/

Patients/ Views & Analysis/ Views and analysis

Health literacy needs support, now more than ever

Dominic Tyer COVID-19, GSK, health literacy, WHO 0 Comment

The COVID-19 pandemic has brought healthcare guidelines and scientific advances front-of-mind on a global scale, in the process

Health literacy needs support, now more than ever

https://pharmaphorum.com/views-analysis-patients/health-literacy-needs-support-now-more-than-ever/

GSK Neale Belson on building trust with employees and society

Sales and Marketing/ Views & Analysis/ Views and analysis

GSK’s Neale Belson on building trust with employees and society

George Underwood climate change, GSK, reputation, Sustainability, UK Leaders 0 Comment

Pharma’s reputation is currently riding high as the industry comes together to tackle COVID-19, but GSK’s UK general

GSK’s Neale Belson on building trust with employees and society

https://pharmaphorum.com/views-analysis-sales-marketing/gsks-neale-belson-on-building-trust-with-employees-and-society/

pharmaphorum_podcast-Episode-25-1200x675

Podcast/ R&D/ Views & Analysis/ Views and analysis

GSK and eosinophil research: the pharmaphorum podcast

Dominic Tyer eosinophil, GSK, podcast 0 Comment

GlaxoSmithKline’s Nucala (mepolizumab) last month became the first and only biologic treatment approved in the US for Hypereosinophilic

GSK and eosinophil research: the pharmaphorum podcast

https://pharmaphorum.com/r-d/gsk-eosinophil-research-podcast/

Digital/ Market Access/ R&D/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

Pharma’s response to COVID: GSK

mike.hammerton@pharmaphorum.com COVID-19, GSK, Pharma’s Response to COVID-19 0 Comment

A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus

Pharma’s response to COVID: GSK

https://pharmaphorum.com/views-analysis-sales-marketing/pharmas-response-to-covid-gsk/

Market Access/ Oncology/ R&D/ Views & Analysis/ Views & Analysis/ Views & Analysis/ Views and analysis

A history of the pharmaceutical industry

Rebecca A history of..., Aspirin, Bayer, Eli Lilly, GSK, History of the pharmaceutical industry, insulin, Merck, NHS, penicillin, Pfizer, Sandoz, Wyeth 0 Comment

Robin Walsh takes a look back at the origins of the industry in the 19th century and its ongoing evolution

A history of the pharmaceutical industry

https://pharmaphorum.com/r-d/a_history_of_the_pharmaceutical_industry/

News/ News/ Oncology

FDA approves GSK’s Blenrep for advanced multiple myeloma

Richard Staines Blenrep, cancer, GSK, multiple myeloma 0 Comment

The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in

FDA approves GSK’s Blenrep for advanced multiple myeloma

https://pharmaphorum.com/news/fda-approves-gsks-blenrep/

Trending

GSK

Login